
Please try another search
Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Name | Age | Since | Title |
---|---|---|---|
Jose Antonio Miguel Neto | 61 | - | Independent Director |
Rodolfo Alfredo Gerardo Hahn | - | - | Chairman of the Board |
Antonio Carlos Buzaid | - | - | Independent Board Member |
Roberto Carlos de Campos Morais | - | 2024 | Chief M&A and Operations (USA and Europe) Officer & Director |
Simone Petroni Agra | - | - | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review